Also trades as: TELO.V (TSXV) · $vol 0M
TDSGF OTC
Telo Genomics Corp.
1W: -9.8%
1M: +55.4%
3M: +21.6%
YTD: -44.1%
1Y: -37.3%
3Y: -88.2%
$0.03
+0.01 (+27.27%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
+5.3% ▲
Capital Expenditures
$3K
+36.5% ▲
5Y CAGR: -17.8%
Free Cash Flow
-$2M
+5.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2K
+99.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$2M | -$3M | -$3M | -$3M |
| Depreciation & Amort. | $62K | $57K | $33K | $40K | $14K |
| Stock-Based Comp. | $142K | $151K | $160K | $65K | $268K |
| Change in Working Capital | -$51K | $107K | -$2K | $158K | $41K |
| Other Non-Cash Items | -$183K | $207K | $0 | -$8K | $685K |
| Operating Cash Flow | -$1M | -$2M | -$3M | -$2M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$9K | -$25K | -$69K | -$5K | -$2K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$9K | -$25K | -$69K | -$5K | -$2K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | -$8K | -$22K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $2M | $877K | -$147K | -$40K | $0 |
| Financing Cash Flow | $4M | $877 | $3M | $587K | $2M |
| Net Change in Cash | $3M | -$944K | -$20K | -$2M | -$2K |
| Cash End of Period | $4M | $3M | $3M | $796K | $580K |
| Free Cash Flow | -$1M | -$2M | -$3M | -$2M | -$2M |